1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Nasal Catarrh in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 10 (76.92) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carratù, L; Ferrara, G; Maniscalco, M; Sofia, M | 1 |
| Ahn, SK; Jeon, SY; Kim, BG; Kim, EA; Kim, JP | 1 |
| Kamei, C; Nakamura, S; Tasaka, K | 1 |
| Woodhead, CJ | 1 |
| Eda, R; Hopp, RJ; Townley, RG | 1 |
| Tsai, JJ; Wang, SR; Yu, LN | 1 |
| Albert, DH; Carter, GW; Curtin, ML; Davidsen, SK; Malo, PE; Morgan, DW; Shaughnessy, TK; Sheppard, GS; Summers, JB; Tapang, P; Wegner, CD; Xu, L | 1 |
| Cromwell, O; Kay, AB; Kurihara, K; Sehmi, R; Waltmann, P; Wardlaw, AJ | 1 |
| Busse, WW; Sedgwick, JB; Vrtis, RR; Zoratti, EM | 1 |
| Iwamura, S; Misawa, M | 1 |
| Atkins, PC; Moskovitz, AR; Taylor, MB; von Allmen, C; Zweiman, B | 1 |
| Barnes, PJ; Chanez, P; Chung, KF; Dent, G; Yukawa, T | 1 |
| Lee, TH | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Nasal Catarrh
| Article | Year |
|---|---|
Neuropeptides in nasal mucosa.
Topics: Bradykinin; Calcitonin Gene-Related Peptide; Cytokines; Eicosanoids; Histamine H1 Antagonists; Humans; Nasal Mucosa; Nasal Polyps; Neurokinin A; Neuropeptide Y; Platelet Activating Factor; Receptors, Calcitonin Gene-Related Peptide; Rhinitis; Substance P; Vasoactive Intestinal Peptide | 1994 |
Asthma and allergic rhinitis.
Topics: Asthma; Humans; Inflammation; Mast Cells; Microcirculation; Nervous System; Platelet Activating Factor; Rhinitis | 1989 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Nasal Catarrh
| Article | Year |
|---|---|
Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects.
Topics: Administration, Intranasal; Adult; Albumins; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Nasal Lavage Fluid; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Premedication; Rhinitis; Statistics, Nonparametric | 2002 |
Rat model of platelet-activating factor-induced rhinosinusitis.
Topics: Administration, Intranasal; Animals; Autacoids; Disease Models, Animal; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rhinitis; Sinusitis | 2005 |
Effects of antiallergic agents including levocabastine on experimental rhinitis in rats.
Topics: Acetylcholine; Animals; Antigens, Helminth; Ascaris; Histamine; Histamine H1 Antagonists; Ketotifen; Male; Nasal Mucosa; Piperidines; Platelet Activating Factor; Rats; Rats, Wistar; Rhinitis; Substance P | 1994 |
Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Topics: Adult; Asthma; Calcimycin; Cell Degranulation; Cell Separation; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Eosinophils; Female; Humans; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Rhinitis; Superoxides; Terfenadine | 1994 |
Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5.
Topics: Asthma; Diterpenes; Eosinophils; Ginkgolides; Humans; Interleukin-5; Lactones; Luminescent Measurements; Luminol; Macrophage-1 Antigen; Phagocytosis; Platelet Activating Factor; Receptors, Complement; Receptors, Complement 3b; Rhinitis; Time Factors | 1993 |
The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis.
Topics: Airway Resistance; Animals; Capillary Permeability; Guinea Pigs; Hypersensitivity; Imidazoles; Indoles; Male; Platelet Activating Factor; Rats; Rats, Inbred BN; Rhinitis | 1998 |
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
Topics: Asthma; Chemotaxis, Leukocyte; Eosinophilia; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-5; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Rhinitis | 1992 |
The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils.
Topics: Adult; Asthma; Azepines; Calcium; Chelating Agents; Dose-Response Relationship, Drug; Eosinophils; Female; Fluorescent Dyes; Humans; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Rhinitis; Superoxides; Triazoles | 1991 |
Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs.
Topics: Animals; Capillary Permeability; Capillary Resistance; Evans Blue; Guinea Pigs; Histamine; Male; Nasal Mucosa; Platelet Activating Factor; Rhinitis | 1990 |
Platelet-activating factor- and leukotriene B4-induced release of lactoferrin from blood neutrophils of atopic and nonatopic individuals.
Topics: Adult; Cytochalasin B; Enzyme-Linked Immunosorbent Assay; Female; Humans; In Vitro Techniques; Lactoferrin; Lactones; Leukotriene B4; Male; Neutrophils; Plant Extracts; Platelet Activating Factor; Rhinitis; Tetradecanoylphorbol Acetate | 1990 |
Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester.
Topics: Adult; Aged; Asthma; Eosinophils; Female; Free Radicals; Humans; Luminescent Measurements; Male; Middle Aged; Oxygen; Oxygen Consumption; Platelet Activating Factor; Pulmonary Eosinophilia; Rhinitis; Tetradecanoylphorbol Acetate | 1990 |